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uate the difference in outcome between open surgery and fenestrated
endovascular aneurysm repair (FEVAR), with a particular focus on renal
function.1 New onset of renal insufﬁciency was detected in 26.5% of the
open surgery group and 8.5% of the endovascular group, which was
persistent in 11.8% and 5.7%, respectively. Three per cent of the patients
in each group required dialysis in the longer term.The rate of renal failure
after open repair and after FEVAR in a recent systematic review were
13.9% and 11.4%, respectively, with no difference in the rate of perma-
nent dialysis between the groups (2.8% and 1.9%, respectively).2 In a
propensity-matched comparison, the rates of perioperative renal insufﬁ-
ciency were 2.7% after open repair and 7.1% after FEVAR (p ¼ .1); the
FEVAR group were initially considered to be high risk for open surgery.3
Despite the transient nature of postoperative renal dysfunction, in most
cases it remains a signiﬁcant predictor of mortality in these patients.
Serum creatinine is the most commonly reported marker of renal
function, but estimated glomerular ﬁltration rate (eGFR) can offer
greater functional sensitivity.4 Renal volume has been assessed in
various urological studies as a predictor of graft function in living donor
renal transplantation. It can be calculated from computed tomography
(CT) data and has been shown in the context of endovascular aneurysm
repair to be an early marker of renal dysfunction and to correlate well
with eGFR.5
Renal impairment in FEVAR is related to the nephrotoxicity of the
contrast medium, micro- and macro-embolisation into the renal arteries
during device manipulation in the aorta, and the inﬂammatory response
associated with the procedure. Carbon dioxide has been used as a
contrast medium in patients with renal failure, but it is associated with a
high complication rate including right heart strain and fatal non-
occlusive mesenteric ischaemia.6 The repositionability of the Cook and
Anaconda stent-grafts is intended to allow better alignment between
the device and the renal artery ostia but it may also cause embolisation
of athero-embolic material into the renal arteries. Other endovascular
considerations include the design of the bridging stents, the amount of
ﬂaring of the proximal end, and the anatomy of the renal artery.
Aortic cross-clamping during open surgical repair results in renal
hypoperfusion and every additional 5 minutes of renal ischaemia time
has been shown to double the risk of postoperative renal dysfunction.7
Clamp placement above both renal arteries, and manipulation of the
aorta and renal arteries results in embolisation of material and this ef-
fect is compounded by ischaemia-reperfusion injury. Division of the left
renal vein increases the risk of renal dysfunction by six times.7 Perfusion
of the renal arteries with cold crystalloid solution may preserve renal
function during thoracoabdominal aneurysm repair but is not widely
used in juxtarenal aneurysm repair.
Imaging surveillance is mandatory after FEVAR but repeated CT
angiography exposes the patient to nephrotoxic iodinated contrast
agent. Studies investigating the effect of different CT contrast agents on
renal kinetics and renal oxygenation have shown that low osmolar
compared with iso-osmolar contrast agents have a superior proﬁleDOI of original article: http://dx.doi.org/10.1016/j.ejvs.2015.04.028
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http://dx.doi.org/10.1016/j.ejvs.2015.07.008regarding rapid excretion, short-term renal exposure, and renal
oxygenation.8 Surveillance is currently changing from repeated CT
angiography to immediate post-EVAR cone-beam CT in the hybrid room
with ultrasound performed prior to hospital discharge.9 CT angiograms
are then performed at years 1 and 3 in the presence of good renal
function with ultrasound performed annually. Ultrasound provides a
hemodynamic evaluation of the bridging stents and target vessels, and
the CT images are used to verify device integrity and positioning.
Contrast-enhanced ultrasound has been shown to be as accurate as CT
scan in detecting endoleaks and in assessing both target vessel patency
and aortic diameter after fenestrated endovascular repair.10
Future work should be directed towards investigation of potential
biomarkers to predict risk, prognosis, and therapeutic response in pa-
tients with acute kidney injury. Renal impairment should be assessed
with eGFR, which is a sensitive and reliable measure of renal function.
Deﬁnite evidence of a difference between open surgical repair and
FEVAR would require a randomised controlled trial and long term follow-
up of 5e10 years.
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